Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
Br J Haematol. 2023 Jun;201(5):954-970. doi: 10.1111/bjh.18692. Epub 2023 Feb 20.
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia. This bibliometric analysis was applied to identify the characteristics of global scientific output, the hotspots, and frontiers of ITP over the past 10 years. We retrieved publications from 2011 to 2021 from the Web of Science Core Collection (WoSCC). Bibliometrix package, VOSviewer, and Citespace were used to analyse and visualize the trend, distribution, and hotspots of research on ITP. Altogether, there were 2084 papers, written by 9080 authors from 410 organizations in 70 countries/regions, published in 456 journals with 37 160 co-cited references. In the last decades, the most productive journal was British Journal of Haematology, China was the most productive country. and the most cited journal was Blood. Shandong University was the most productive institution in the field of ITP. NEUNERT C, 2011, BLOOD, CHENG G, 2011, LANCET, and PATEL VL, 2012, BLOOD were the top three most cited documents. "Thrombopoietin receptor agonist", "regulatory T cell" and "sialic acid" were three hotspots of the last decade. And "immature platelet fraction", "Th17", and "fostamatinib" would be research frontiers in the feature. The present study provided a novel insight for future research directions and scientific decision-making.
原发性免疫性血小板减少症(ITP)是一种以孤立性血小板减少为特征的自身免疫性疾病。本文献计量分析旨在确定过去 10 年全球科学产出的特点、热点和 ITP 的前沿。我们从 Web of Science Core Collection(WoSCC)中检索了 2011 年至 2021 年的出版物。使用 Bibliometrix 包、VOSviewer 和 Citespace 分析和可视化 ITP 研究的趋势、分布和热点。共有 2084 篇论文,作者来自 70 个国家/地区的 410 个机构,发表在 456 种期刊上,被引次数为 37160 次。在过去的几十年里,最具生产力的期刊是《英国血液学杂志》,中国是最具生产力的国家,被引最多的期刊是《血液》。山东大学是 ITP 领域最具生产力的机构。NEUNERT C,2011,血液,程刚,2011,柳叶刀,和 PATEL VL,2012,血液是被引最多的三篇文献。“血小板生成素受体激动剂”、“调节性 T 细胞”和“唾液酸”是过去十年的三个热点。而“未成熟血小板分数”、“Th17”和“福他替尼”将是该领域的研究前沿。本研究为未来的研究方向和科学决策提供了新的见解。
Br J Haematol. 2023-6
Front Immunol. 2023
Medicine (Baltimore). 2024-8-9
Front Endocrinol (Lausanne). 2023
Childs Nerv Syst. 2024-12-5
Blood Adv. 2024-7-23
Front Immunol. 2023